TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis.
Melotti S, Ambrosi F, Franceschini T, Giunchi F, Filippo GD, Franchini E, Massari F, Mollica V, Tateo V, Bianchi FM, Colecchia M, Acosta AM, Lobo J, Fiorentino M, Ricci C.
Pathol Res Pract. 2023 Jul;247:154540. doi: 10.1016/j.prp.2023.154540. Epub 2023 May 18.
PMID:37209574
[Management of residual masses of testis germ cell tumors].
Tremeau L, Mottet N.
Bull Cancer. 2020 Feb;107(2):215-223. doi: 10.1016/j.bulcan.2019.10.010. Epub 2019 Dec 24.
PMID:31882267
Mixed germ cell-sex cord stromal tumour of the testis and ovary: comparison and contrast.
Roth LM, Cheng L.
Pathology. 2021 Feb;53(2):166-169. doi: 10.1016/j.pathol.2020.10.008. Epub 2020 Dec 25.
PMID:33358757
The role of dead-end in germ-cell tumor development.
Zhu R, Bhattacharya C, Matin A.
Ann N Y Acad Sci. 2007 Dec;1120:181-6. doi: 10.1196/annals.1411.006. Epub 2007 Sep 28.
PMID:17905939
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M, Paffenholz P, Ruf C, Che Y, Seidel C, Heinzelbecker J, Schmelz HU, Matthies C, Albers P, Bokemeyer C, Heidenreich A, Pichler M, Nestler T; GTCSG (German Testicular Cancer Study Group).
Cancer Med. 2023 Aug;12(16):16829-16836. doi: 10.1002/cam4.6304. Epub 2023 Jul 1.
PMID:37392170
Primary Cystic Trophoblastic Tumor of the Testis: A Study of 14 Cases.
Gondim DD, Ulbright TM, Cheng L, Idrees MT.
Am J Surg Pathol. 2017 Jun;41(6):788-794. doi: 10.1097/PAS.0000000000000830.